Tag Archives: 10th IAS Conference on HIV Science (IAS 2019)

New studies inform WHO’s decision on the use of dolutegravir in women of childbearing age  

The safety of the HIV treatment drug, dolutegravir (DTG), during pregnancy has been one of the most urgent questions in global health for the past year. At the 22nd International AIDS Conference (AIDS 2018) last year, data from the Tsepamo study in Botswana suggested that the use of DTG in early pregnancy may be linked

ECHO study finds high rates of HIV and STIs among young women in 4 African countries

Henry Opondo New evidence from eSwatini, Kenya, South Africa and Zambia presented at the 10th IAS Conference on HIV Science (IAS 2019) in Mexico show high rates of HIV incidence overall among young women in these countries. The highly-publicized Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial, which just a few weeks ago finally

Top